AFJK
Aimei Health Technology Co., Ltd NASDAQ$43.50
After hrs
$43.60
-3.09%
Mkt Cap $266.3M
52w Low $6.75
29.7% of range
52w High $130.37
50d MA $34.98
200d MA $27.11
P/E (TTM)
164.9x
EV/EBITDA
-90.9x
P/B
5.8x
Debt/Equity
0.0x
ROE
-62.8%
P/FCF
-143.7x
RSI (14)
—
ATR (14)
—
Beta
-1.50
50d MA
$34.98
200d MA
$27.11
Avg Volume
19.5K
About
Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. …
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | AMC | — | 0.06 | — | 10.52 | -2.9% | -1.2% | -6.7% | -4.5% | -4.0% | +7.6% | — |
| Aug 13, 2025 | AMC | — | 0.07 | — | 11.21 | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | — |
| May 14, 2025 | AMC | — | 0.03 | — | 11.03 | +0.5% | +0.5% | +1.1% | +0.9% | +1.5% | +1.5% | — |
| Mar 28, 2025 | AMC | — | 0.05 | — | 11.00 | +0.0% | +0.0% | +0.0% | -0.2% | +0.0% | -0.1% | — |
| Nov 13, 2024 | AMC | — | 0.08 | — | 10.64 | -0.4% | -0.4% | -0.7% | -0.5% | -0.4% | -0.4% | — |
| Aug 9, 2024 | AMC | — | 0.07 | — | 10.40 | +0.0% | -0.1% | -0.2% | +0.0% | +0.0% | +0.0% | — |
| May 13, 2024 | AMC | — | 0.08 | — | 10.30 | +0.0% | +0.0% | +0.0% | +0.0% | +0.1% | +0.1% | — |
| Mar 25, 2024 | AMC | — | 0.02 | — | 10.19 | +0.1% | +0.3% | +0.7% | +0.7% | +0.7% | +1.1% | — |
Recent Filings
8-K
Aimei Health Technology Co., Ltd -- 8-K Filing
Aimei Health Technology (AFJK) faces a Nasdaq delisting threat but plans to appeal and is working to file its overdue Annual Report to regain compliance.
Apr 21
8-K · 2.03
! Medium
Unknown — 8-K 2.03: Credit Facility
AFJK's pending merger with United Hydrogen requires a promissory note payment at close, increasing deal costs and potentially diluting shareholders if the company needs additional financing to cover obligations.
Apr 7
NT 10-K
!!! Very High
Unknown — Late Annual Report — Distress Signal
AFJK's late annual report filing signals potential financial distress or operational challenges, creating uncertainty about the company's health and increasing delisting risk for shareholders.
Apr 1
8-K · 2.03
! Medium
Aimei Health Technology Co., Ltd -- 8-K 2.03: Credit Facility
Aimei Health Technology (AFJK) secured a credit facility extension, marking the sixteenth permitted extension under its amended articles, adding financial obligations to the company's balance sheet.
Mar 4
8-K · 2.03
! Medium
Aimei Health Technology Co., Ltd -- 8-K 2.03: Credit Facility
Aimei Health Technology (AFJK) secured a credit facility extension, marking the fifteenth permitted extension under its amended articles, indicating ongoing capital access but potential reliance on repeated refinancing.
Feb 13
Data updated apr 24, 2026 4:25pm
· Source: massive.com